Operating Profit Changement Date
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amarin USD -21451000 2.51M 2023-09
Amgen USD 1.27B 819M 2023-12
Baxter International USD 299M 350M 2023-12
Cara Therapeutics USD -28898000 3.44M 2023-09
Cytokinetics USD -127418000 5.15M 2023-12
Eli Lilly USD 2.39B 1.94B 2023-12
Esperion Therapeutics USD -27533000 9.52M 2023-09
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Intra Cellular Therapies USD -34097000 4.38M 2023-12
Intrexon USD -20937000 183K 2023-09
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
MannKind USD 7.86M 2.76M 2023-12
Minerva Neurosciences USD -6079000 1.56M 2023-09
Nektar Therapeutics USD -44864000 5.74M 2023-09
Peregrine Pharmaceuticals USD -11222000 9.06M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Rigel Pharmaceuticals USD -4465000 802K 2023-09
United Therapeutics USD 260.1M 66.9M 2023-12
Vanda Pharmaceuticals USD -2867000 4.87M 2023-06



Halozyme Therapeutics Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.